HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preparation and functional evaluation of RGD-modified streptavidin targeting to integrin-expressing melanoma cells.

Abstract
The vertical growth stage is the most dangerous stage of melanoma and is often associated with a poor prognosis. The increased invasiveness and metastasis that is typical for vertically growing melanoma are mediated by the molecules of cell adhesion (particularly, integrins). Integrin αvβ3, which is abundantly expressed on melanoma cells with high metastatic potentials and is characterized by low expression levels in normal melanocytes, is potentially an attractive target for melanoma diagnostics and therapy. Integrin αvβ3 is known to recognize the arginine-glycine-aspartic (RGD) sequence, which has been found in a wide variety of its natural ligands. Here expression vectors bearing the genes of fusion proteins have been constructed for producing these proteins in Escherichia coli. Such fusion proteins consist of a peptidic 'address,' targeting the integrins on melanoma cells, linked to an 'adaptor' for the attachment of a diagnostic or toxic agent. The peptidic 'address' contains the RGD motif, which is stabilized by a disulfide bond to achieve the optimal receptor binding conformation. The 'adaptor' is a tetrameric protein, namely, streptavidin, that is able to achieve high-affinity binding of d-biotin (K(d) = 10(-15) M) and confer avidity to the address peptide. This binding ability facilitates the generation of anti-melanoma diagnostic and therapeutic agents using the appropriate biotin derivatives. These recombinant proteins were purified from the periplasm of E.coli using columns with 2-iminobiotin agarose and demonstrated an ability to adhere to the surface of murine and human melanoma cells.
AuthorsMarina S Syrkina, Dmitry A Shirokov, Mikhail A Rubtsov, Elena L Kadyrova, Vladimir P Veiko, Valentin A Manuvera
JournalProtein engineering, design & selection : PEDS (Protein Eng Des Sel) Vol. 26 Issue 2 Pg. 143-50 (Feb 2013) ISSN: 1741-0134 [Electronic] England
PMID23161915 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fluorescent Dyes
  • Integrin alphaVbeta3
  • Oligopeptides
  • Recombinant Fusion Proteins
  • trypsinogen activation peptide
  • arginyl-glycyl-aspartic acid
  • Streptavidin
  • Enteropeptidase
  • Fluorescein-5-isothiocyanate
Topics
  • Animals
  • Cattle
  • Cell Line, Tumor
  • Chromatography, Gel
  • Enteropeptidase (chemistry)
  • Escherichia coli
  • Fluorescein-5-isothiocyanate (chemistry)
  • Fluorescent Dyes (chemistry)
  • Humans
  • Integrin alphaVbeta3 (metabolism)
  • Male
  • Melanoma
  • Mice
  • Oligopeptides (biosynthesis, chemistry, genetics)
  • Protein Binding
  • Protein Engineering
  • Proteolysis
  • Recombinant Fusion Proteins (biosynthesis, chemistry, genetics)
  • Staining and Labeling
  • Streptavidin (biosynthesis, chemistry, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: